Eisai

Eisai is a pharmaceutical company founded in 1941 and headquartered in Japan. They focus on developing innovative drugs for neurological and oncological diseases. Their portfolio includes treatments for Alzheimer's disease, epilepsy, and various types of cancer. Eisai is known for its commitment to research and development in the field of neuroscience and its dedication to improving the quality of life for patients with neurological disorders.